Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NMRA	NEUMORA THERAPEUTICS INC	$80.61M	-242.30%	-131.30%	-211.61%	-597.70%	1.81	4.50	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$50.37M	N/A	-511.40%	44,702.68%	1,700.20%	-1.78	0.89	N/A	N/A	N/A
LTRN	LANTERN PHARMA INC	$5.54M	-456.40%	-184.30%	-435.83%	27,389.90%	-3.67	1.96	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$7.64M	-3,552.70%	-352.40%	-991.94%	-325.00%	-5.79	0.35	N/A	N/A	N/A
XBIT	XBIOTECH INC	$59.76M	-33.00%	-31.60%	-34.45%	-217.90%	0.04	39.51	N/A	N/A	N/A
LSTA	LISATA THERAPEUTICS INC	$10.90M	-113.80%	-90.50%	-186.67%	755.30%	0.37	3.69	100.00%	-14,621.00%	-15,008.00%
OKYO	OKYO PHARMA LTD	$70.85M	-263.80%	-72.60%	-68.91%	181.40%	0.70	2.43	N/A	N/A	N/A
XRTX	XORTX THERAPEUTICS INC	$1.90M	-137.90%	-108.20%	-67.93%	-329.20%	0.12	3.59	N/A	N/A	N/A
LPCN	LIPOCINE INC	$18.94M	-46.50%	-41.80%	-44.09%	-59.80%	0.10	11.36	100.00%	-249.20%	-249.15%
TVGN	TEVOGEN INC	$39.07M	N/A	-478.10%	1,534.86%	-399.20%	-1.53	0.33	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$4.02M	N/A	-622.30%	-3,426.48%	442.20%	10.32	1.12	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$7.34M	-160.70%	-143.90%	-175.71%	-1,299.10%	0.09	10.60	100.00%	-3,985.60%	-3,983.31%
KTTA	PASITHEA THERAPEUTICS CORP	$19.18M	-48.80%	-46.20%	-56.78%	3,022.10%	0.06	15.67	N/A	N/A	N/A
APLM	APOLLOMICS INC	$39.16M	N/A	-107.70%	77.99%	160.50%	0.00	0.15	N/A	N/A	N/A
KPRX	KIORA PHARMACEUTICALS INC	$5.44M	-82.10%	-55.70%	-66.62%	-128.70%	0.46	7.91	100.00%	-1,276.30%	-1,322.80%
KAPA	KAIROS PHARMA LTD	$2.13M	-129.60%	-121.10%	-164.93%	-447.00%	0.13	6.77	N/A	N/A	N/A
JUNS	JUPITER NEUROSCIENCES INC	$1.36M	N/A	-232.80%	5,547.93%	3,450.40%	-11.16	0.66	81.80%	-14,220.10%	-13,798.25%
JAGX	JAGUAR HEALTH INC	$144.37k	N/A	-131.50%	-401.61%	-277.10%	4.43	0.69	82.30%	-188.50%	-127.26%
INTS	INTENSITY THERAPEUTICS INC	$10.17M	-124.30%	-99.90%	-156.21%	5,121.70%	0.34	3.68	N/A	N/A	N/A
IMA	IMAGENEBIO INC	$43.22M	-32.90%	-29.70%	-34.46%	-88.20%	0.11	16.17	N/A	N/A	N/A
IGC	IGC PHARMA INC	$21.00M	-123.90%	-85.10%	-122.34%	-588.20%	0.50	0.42	16.50%	-643.70%	-643.65%
ADXN	ADDEX THERAPEUTICS LTD	$4.14M	-172.60%	-125.30%	-324.35%	-234.70%	0.82	0.76	100.00%	-8,271.00%	-8,263.75%
LABT	LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC	$668.25k	N/A	-443.70%	-166.77%	-29,672.30%	0.15	7.70	N/A	N/A	N/A
IBO	IMPACT BIOMEDICAL INC	$44.41M	14.40%	9.50%	-6.87%	65.20%	0.30	0.04	-1,028.90%	4,247.40%	-2,542.11%
VALN	VALNEVA SE	$536.70M	-152.10%	-39.20%	-41.05%	-32.90%	3.79	2.16	16.40%	-110.30%	-81.83%
AZTR	AZITRA INC	$3.68M	-191.60%	-155.50%	-280.59%	-1,233.40%	0.36	3.11	N/A	N/A	N/A
ERNA	ERNEXA THERAPEUTICS INC	$2.84M	-332.50%	-187.60%	-314.05%	1,255.90%	0.63	2.57	N/A	N/A	N/A
MTRI	MENTARI THERAPEUTICS INC	$10.22M	-332.50%	-220.50%	1,096.72%	4,645.70%	-2.09	0.50	22.50%	-1,657.70%	-1,603.78%
VIVS	VIVOSIM LABS INC	$2.58M	-498.60%	-146.10%	-141.58%	-11,114.40%	0.37	3.50	58.50%	-7,605.90%	-7,594.81%
GRI	GRI BIO INC	$3.72M	-87.60%	-75.90%	-88.63%	813.50%	0.11	10.21	N/A	N/A	N/A
GOVX	GEOVAX LABS INC	$928.29k	-1,010.80%	-420.00%	-1,416.70%	-15,383.00%	1.98	1.46	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$5.75M	-789.10%	-153.40%	-181.95%	11,175.70%	0.38	2.75	38.50%	-15,526.40%	-14,153.85%
KYNB	KYNTRA BIO INC	$13.93M	-605.50%	156.80%	295.95%	218.90%	-3.62	2.69	6.30%	3,967.80%	4,168.98%
IPHA	INNATE PHARMA SA	$129.48M	N/A	-74.30%	-2,446.20%	-174.40%	-1.86	0.60	100.00%	-483.80%	-466.39%
BBTX	BAMBUSA THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-2.09	6.16	N/A	N/A	N/A
EVGN	EVOGENE LTD	$5.01M	N/A	-46.80%	-41.11%	-50.40%	-2.33	3.57	-190.20%	-948.10%	-446.60%
EXOZ	EXOZYMES INC	$36.15M	-376.70%	-170.20%	-240.73%	-473.60%	1.68	2.30	N/A	N/A	N/A
HRTX	HERON THERAPEUTICS INC	$58.98M	-244.30%	-8.80%	-9.89%	-5.10%	45.88	2.33	71.50%	-14.50%	-9.38%
VRAX	VIRAX BIOLABS GROUP LTD	$355.06k	-75.70%	-68.10%	-76.73%	-333.40%	0.13	9.97	61.90%	-40,439.10%	-47,188.42%
TCRX	TSCAN THERAPEUTICS INC	$10.91M	-140.70%	-61.90%	-108.34%	-84.80%	2.72	2.03	100.00%	-2,219.20%	-2,163.94%
SLN	SILENCE THERAPEUTICS PLC	$935.96M	N/A	-48.00%	-63.98%	-103.30%	-1.77	7.42	85.90%	-9,748.50%	-9,748.13%
SER	SERINA THERAPEUTICS INC	$36.93M	-217.90%	-133.60%	-136.51%	-1,429.80%	0.57	4.62	100.00%	-21,890.40%	-18,941.60%
ENSC	ENSYSCE BIOSCIENCES INC	$8.13M	-1,235.40%	-838.10%	-335.63%	5,793.70%	0.14	8.02	N/A	N/A	N/A
PCSA	PROCESSA PHARMACEUTICALS INC	$5.20M	N/A	-393.40%	-107.22%	-240,296.10%	-0.01	97.70	N/A	N/A	N/A
BCDA	BIOCARDIA INC	$12.57M	-912.40%	-237.00%	-783.76%	698.20%	2.68	1.12	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$1.85M	-107.90%	-25.50%	-9.57%	-37.00%	1.74	1.27	27.50%	-275.70%	-238.27%
INAB	IN8BIO INC	$8.86M	-93.70%	-78.40%	-120.78%	-433.90%	0.32	5.78	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$8.34M	-3,029.60%	-107.90%	-120.63%	-182.80%	2.38	4.96	N/A	N/A	N/A
IMRN	IMMURON LTD	$7.06M	-38.70%	-31.90%	-32.25%	-95.50%	0.18	7.26	69.20%	-41.40%	-41.26%
CURX	CURANEX PHARMACEUTICALS INC	$7.53M	-185.20%	-175.10%	-417.44%	-315.80%	0.22	17.84	N/A	N/A	N/A
ENVB	ENVERIC BIOSCIENCES INC	$6.78M	-232.70%	-202.10%	-107.99%	4,045.10%	0.11	10.21	N/A	N/A	N/A
CRIS	CURIS INC	$940.54k	-1,035.30%	-87.90%	-399.49%	272.40%	3.04	0.49	99.70%	-490.30%	-490.33%
DARE	DARE BIOSCIENCE INC	$10.05M	-748.10%	-38.70%	-201.69%	109.30%	-40.94	0.99	37.20%	-804.40%	-804.37%
CTXR	CITIUS PHARMACEUTICALS INC	$14.69M	-67.10%	-33.90%	-50.29%	-61.40%	1.00	0.84	77.30%	-651.30%	-641.34%
DYAI	DYADIC INTERNATIONAL INC	$13.23M	N/A	-86.90%	-199.74%	-148.30%	-4.08	1.69	17.90%	-226.90%	-212.54%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$1.37B	-240.30%	-46.90%	-103.92%	-86.40%	4.81	1.22	93.90%	-228.50%	-217.94%
CMND	CLEARMIND MEDICINE INC	$1.21M	-88.50%	-61.60%	-57.34%	-4,372.20%	0.31	4.31	N/A	N/A	N/A
COCP	COCRYSTAL PHARMA INC	$18.88M	-207.50%	-123.30%	-488.83%	-551.40%	3.45	1.24	N/A	N/A	N/A
CNTX	CONTEXT THERAPEUTICS INC	$16.63M	-96.50%	-83.60%	-141.41%	1,170.80%	0.18	6.59	N/A	N/A	N/A
CMMB	CHEMOMAB THERAPEUTICS LTD	$11.53M	-70.40%	-62.60%	-86.97%	-184.70%	0.18	6.41	N/A	N/A	N/A
CLRB	CELLECTAR BIOSCIENCES INC	$11.44M	-161.20%	-111.80%	-107.97%	3,137.60%	0.33	4.44	N/A	N/A	N/A
ABOS	ACUMEN PHARMACEUTICALS INC	$15.48M	-166.50%	-90.80%	-246.34%	-192.00%	1.47	1.89	N/A	N/A	N/A
CLLS	CELLECTIS SA	$85.82M	-319.90%	-46.50%	-149.85%	-53.30%	-13.10	1.16	100.00%	-396.80%	-336.69%
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$5.27M	-215.60%	-121.30%	-265.42%	-239.40%	1.44	1.57	-321.70%	-3,934.90%	-3,932.08%
CLDI	CALIDI BIOTHERAPEUTICS INC	$2.15M	-483.80%	-208.90%	-879.35%	-1,681.10%	2.39	1.27	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$39.11M	-102.70%	-69.40%	-100.13%	-76.70%	0.61	4.97	100.00%	-1,085.00%	-1,090.82%
ESLA	ESTRELLA IMMUNOPHARMA INC	$22.36M	N/A	-328.80%	134.74%	105.40%	-1.25	0.20	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$3.89M	-59.00%	-49.50%	-82.94%	546.50%	0.43	3.15	100.00%	-123.70%	-123.71%
TLX	TELIX PHARMACEUTICALS LTD	$3.14B	N/A	N/A	N/A	N/A	1.79	2.01	N/A	N/A	N/A
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$4.01M	-102.00%	-96.70%	-107.00%	5,050.20%	0.04	23.66	66.90%	-249,160.10%	-249,160.10%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$5.59M	-89.40%	-82.80%	-110.99%	-439.00%	0.06	17.44	100.00%	-42,721.90%	-42,646.43%
AKBA	AKEBIA THERAPEUTICS INC	$131.61M	-169.20%	-12.50%	-15.27%	-132.20%	15.80	1.36	78.90%	-22.60%	-13.92%
CBUS	CIBUS INC	$86.60M	-581.50%	-31.10%	-20.42%	-19.80%	-54.17	0.95	100.00%	-2,131.40%	-1,295.81%
EYPT	EYEPOINT INC	$35.27M	-168.80%	-130.90%	-268.24%	-229.10%	0.53	3.30	44.70%	-13,281.20%	-13,274.68%
CANF	CAN-FITE BIOPHARMA LTD	$3.04M	N/A	N/A	N/A	N/A	0.66	3.60	N/A	N/A	N/A
BRTX	BIORESTORATIVE THERAPIES INC	$1.90M	-423.80%	-193.30%	-365.43%	-3,005.60%	0.53	2.35	92.10%	-3,089.60%	-3,089.55%
RNAZ	TRANSCODE THERAPEUTICS INC	$22.35M	N/A	-38.90%	-29.10%	6,080.50%	-0.46	1.97	N/A	N/A	N/A
BYSI	BEYONDSPRING INC	$24.71M	N/A	-30.20%	-1,536.32%	-266.00%	-1.42	0.70	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-42.00%	-32.10%	-41.83%	-215.10%	0.32	2.41	N/A	N/A	N/A
BOLT	BOLT BIOTHERAPEUTICS INC	$11.71M	-126.20%	-54.70%	-88.49%	-54.30%	2.19	2.61	100.00%	-611.50%	-611.47%
CNSP	CNS PHARMACEUTICALS INC	$4.22M	-204.30%	-141.90%	-91.67%	995.20%	0.21	5.87	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$1.42M	-639.50%	-85.10%	-57.91%	-47.90%	2.60	0.06	96.40%	-331.10%	-70.32%
OGEN	ORAGENICS INC	$902.39k	-200.10%	-146.10%	-899.65%	-1,188.50%	2.00	1.50	N/A	N/A	N/A
CSBR	CHAMPIONS ONCOLOGY INC	$65.56M	-27.10%	-3.70%	-5.91%	-9.50%	7.41	1.03	49.80%	-1.80%	-1.42%
ICCC	IMMUCELL CORP	$97.73M	6.20%	4.10%	4.45%	4.10%	0.46	4.61	40.80%	5.70%	5.79%
BLRX	BIOLINERX LTD	$6.81M	-54.50%	-24.30%	-41.65%	-1,330.70%	1.22	1.20	80.00%	-667.30%	-592.46%
CVKD	CADRENAL THERAPEUTICS INC	$5.39M	-406.40%	-273.80%	-282.13%	3,842.70%	0.37	3.73	N/A	N/A	N/A
ACXP	ACURX PHARMACEUTICALS INC	$5.82M	-116.60%	-84.00%	-110.25%	346.60%	0.41	3.45	N/A	N/A	N/A
XTLB	XTL BIOPHARMACEUTICALS LTD	$4.54M	-269.00%	-159.90%	2,740.94%	1,450.40%	-1.65	0.40	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$9.89M	-57.90%	-45.60%	-60.20%	-70.40%	0.33	2.64	96.90%	-1,076.50%	-1,070.15%
EOCN	EOCENE LTD	$2.48M	-73.70%	-60.90%	-78.04%	-105.60%	0.44	4.16	N/A	N/A	N/A
CUVL	CLINUVEL PHARMACEUTICALS LTD	$254.66M	13.40%	12.20%	17.16%	20.50%	0.08	14.72	82.90%	36.00%	50.87%
MTVA	METAVIA INC	$8.77M	-265.50%	-129.90%	-629.19%	304.80%	2.96	1.33	N/A	N/A	N/A
IMMP	IMMUTEP LTD	$25.64M	-77.30%	-66.00%	-114.66%	-207.90%	0.35	5.69	100.00%	-328.10%	-327.84%
DWTX	DOGWOOD THERAPEUTICS INC	$42.43M	-35.00%	-29.50%	-37.95%	3,411.60%	0.18	2.78	11.90%	-25,179.60%	-27,868.75%
MOLN	MOLECULAR PARTNERS AG	$112.62M	-79.20%	-61.90%	-92.13%	-647.50%	0.27	6.46	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$19.56M	-117.10%	-96.10%	-159.41%	8,073.40%	0.22	5.35	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$51.56M	83.40%	23.40%	36.60%	-371.10%	0.33	4.08	100.00%	32.20%	32.23%
XCUR	EXICURE INC	$7.07M	-237.90%	-62.00%	-123.38%	596.60%	10.67	0.56	N/A	N/A	N/A
XLO	XILIO THERAPEUTICS INC	$57.04M	-18.50%	-7.60%	-10.64%	57.10%	0.98	4.72	100.00%	-20.90%	-20.89%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Xeris Biopharma Holdings (NASDAQ:XERS)

Xeris Biopharma Holdings (NASDAQ:XERS) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Xeris Biopharma Holdings (NASDAQ:XERS) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: B.

Xeris Biopharma Holdings (NASDAQ:XERS) has a Due Diligence Score of 39, which is 15 points higher than the biotech industry average of 24.

XERS passed 13 out of 33 due diligence checks and has average fundamentals. Xeris Biopharma Holdings has seen its stock return 129.48% over the past year, overperforming other biotech stocks by 225 percentage points.

Xeris Biopharma Holdings has an average 1 year price target of $17.00, an upside of 2.04% from Xeris Biopharma Holdings's current stock price of $16.66.

Xeris Biopharma Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Xeris Biopharma Holdings, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Regeneron Pharmaceuticals (NASDAQ:REGN) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Regeneron Pharmaceuticals (NASDAQ:REGN) has a Due Diligence Score of 47, which is 23 points higher than the biotech industry average of 24.

REGN passed 18 out of 38 due diligence checks and has strong fundamentals. Regeneron Pharmaceuticals has seen its stock return 37.48% over the past year, overperforming other biotech stocks by 133 percentage points.

Regeneron Pharmaceuticals has an average 1 year price target of $904.29, a downside of -5.36% from Regeneron Pharmaceuticals's current stock price of $955.47.

Regeneron Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 24 analysts covering Regeneron Pharmaceuticals, 58.33% have issued a Strong Buy rating, 8.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Fennec Pharmaceuticals (NASDAQ:FENC) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Fennec Pharmaceuticals (NASDAQ:FENC) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

FENC passed 17 out of 33 due diligence checks and has strong fundamentals. Fennec Pharmaceuticals has seen its stock return 51.11% over the past year, overperforming other biotech stocks by 147 percentage points.

Fennec Pharmaceuticals has an average 1 year price target of $16.67, an upside of 43.43% from Fennec Pharmaceuticals's current stock price of $11.62.

Fennec Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Fennec Pharmaceuticals, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 8 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)

Rallybio (NASDAQ:RLYB) has an annual dividend yield of 86.26%, which is 73 percentage points higher than the biotech industry average of 12.82%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.74%, which is -6 percentage points lower than the biotech industry average of 12.82%.

Oramed Pharmaceuticals's dividend payout ratio of 7.1% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.45%, which is -8 percentage points lower than the biotech industry average of 12.82%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 48.3% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 0.7% over the last week. Oragenics was the among the top losers in the biotechnology industry, dropping -42.86% yesterday.

Oragenics shares are trading lower. The stock initially rallied yesterday after the company announced it had been granted an extension to regain NYSE compliance, but it has since reversed.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.55% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has dropped -14.28% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

3. Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics (NASDAQ:ZVRA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Zevra Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Zevra Therapeutics's stock has dropped -1.63% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

Are biotech stocks a good buy now?

62.71% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 79.98% over the next year.

2.25% of biotech stocks have a Zen Rating of A (Strong Buy), 3.83% of biotech stocks are rated B (Buy), 44.82% are rated C (Hold), 36.71% are rated D (Sell), and 12.39% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 18.56x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.